HYDERABAD - November 2009
Advanced Drug Development Services (ADDS) is a European CRO into advanced process of drugs and medical devices development. MakroCare is one of the fastest growing global CROs, situated in India and a leader in providing clinical and medical services at the international level.

These two companies announced this November the signing of an exclusive partnership agreement for Pharmacovigilance and Drug safety services. This partnership allows both the companies to offer their wide range of Clinical, Medical and Safety services to pharmaceutical, biotechnology, and medical devices companies in key territories -Europe/Asia/Africa.

Both the Companies will operate in key strategic areas of practice in the said regions, allowing each other an opportunity to offer their best and cost effective services to their existing and potential clients, leading to a better business outcome as well as successful development.

About ADDS:
Advanced Drug Development Services SAS (ADDS) is a European Contract Research Organisation (CRO), which provides full coverage of Phase II to IV clinical studies for drugs and medical devices in Europe as well as complete Pharmacovigilance and Risk Management services: including complete outsourcing of Pharmacovigilance department, European Qualified Person for Pharmacovigilance, Eudravigilance certification, safety data base and call centre.

About Makrocare:
MakroCare, a global clinical services firm, provides clinical research support to pharmaceutical, biotechnology, and medical devices industries. The company offers site selection, patient recruitment, project and clinical data management, clinical monitoring, medical writing, PMS/Pharmacovigilance, biometrics, call centre service, regulatory assistance, and quality assurance. MakroCare has offices in USA (New Jersey, Illinois, Pennsylvania, and California), India (Hyderabad, Mumbai, Bengaluru and New Delhi), Japan (Tokyo), and Europe (Frankfurt).

BioForum Group (Israel) and ADDS SAS sign exclusive partnership for Safety services

TEL-AVIV – November 2009
In an effort to create a long lasting cooperation BioForum Group (Israel) and ADDS SAS (France) sign exclusive partnership for Safety services.

Both companies announced this November the signing of an exclusive partnership agreement for Pharmacovigilance and Drug safety services. This partnership allows BioForum Group to offer to their Israeli clients a wide range of Safety services via ADDS SAS to pharmaceutical, biotechnology, and medical devices companies in Israel. ADDS SAS will benefit for the fame and the large presence of Bioforum in Israel.

About Bioforum Group:
BioForum is a leading applicable knowledge centre that provides a wide range of education and training activities, experts’ consultation and services. These are targeted to the biotechnology, pharmaceutical and medical device industries and start-up companies, the food and chemical industries as well as medical centres, laboratories and governmental offices.

About ADDS:
Advanced Drug Development Services SAS (ADDS) is a European Contract Research Organisation (CRO), which provides full coverage of Phase II to IV clinical studies for drugs and medical devices in Europe as well as complete Pharmacovigilance and Risk Management services: including complete outsourcing of Pharmacovigilance department, European Qualified Person for Pharmacovigilance, Eudravigilance certification, safety data base and call centre.